Imbio LLC is a Minneapolis-based company that specializes in using artificial intelligence (AI) to transform standard medical imaging into personalized medicine. Their comprehensive product portfolio includes algorithms for lung density analysis, lung texture analysis, RV LV analysis, airway analysis, and coronary calcification. Imbio's breakthrough image analysis tools have been validated on thousands of image series and are trusted by clinicians and researchers in 20 countries. Their secure, scalable, and interoperable Core Compute Platform can be deployed within institutions or in the cloud, making it a versatile solution for physicians, health systems, and patients.
With over 35 peer-reviewed publications and several patents, Imbio's proven technology has been praised by medical professionals worldwide. Their products, such as the Lung Texture Analysis (LTA) and Functional Lung Density Analysis, provide objective measurements for disease progression and treatment response, aiding in the assessment and management of conditions like interstitial lung disease and COPD. Imbio's innovative approach to medical imaging analysis has earned them a reputation for delivering comprehensive intelligence and driving advancements in patient care.
Generated from the website